Observational studyFrontiers in public health2026
The role of digital pharmaceutical governance in alleviating health inequality: a case study of the "Sanya Model" for centralized regional prescription review.
Observational study in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Irrational drug use poses a persistent challenge to healthcare quality and economic efficiency. In the context of China's "Tight-knit Urban Medical Group" reform, this study analyzes a digitized pharmaceutical governance model designed to bridge the gap in pharmaceutical care between tertiary hospitals and primary healthcare facilities. We aimed to analyze the implementation and public health correlation of a Centralized E-prescription Review (CEPR) platform within a regional medical network. Methods: A retrospective, observational real-world study was conducted in Sanya, China. We implemented a CEPR platform utilizing a dual-layered cloud architecture and non-invasive data acquisition (XTL) to integrate regional drug metadata. The system incorporates an AI-driven engine fusing Large Language Models (LLMs) with Retrieval-Augmented Generation (RAG) to provide clinical decision support. A total of 441,327 prescriptions were analyzed over a 12-month longitudinal period. The Cochran-Armitage trend test was employed to evaluate temporal shifts in prescription safety, economic efficiency, and service homogeneity. Results: Following the implementation of the CEPR platform, the initial prescription pass rate at primary healthcare institutions rose significantly from 75.00 to 95.12%, and a 99.30% pharmacist intervention success rate was achieved across more than 16,000 intercepted high-risk orders. Regarding economic efficiency, the average cost per outpatient visit decreased by 4.58%, while inpatient drug costs dropped by 23.5%, accompanied by the implementation of a technology-based integrity oversight mechanism. Notably, the regional irrational prescription rate over 12 consecutive months of operation decreased markedly from 11.92 to 7.35% ( Conclusion: The CEPR model, characterized by the "Sanya Model," serves as a digital lever for enhancing the accessibility and homogeneity of high-quality pharmaceutical services. By shifting medication safety from a site-specific resource to a standardized public service, this framework supports the "Three medical linkage" (San Yi Lian Dong, i.e., the integrated reform of medical services, health insurance, and pharmaceutical systems) collaborative reform. These findings provide a scalable governance paradigm for improving public health resilience in regions with unevenly distributed medical resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.